Interobserver Agreement of visual and semi-quantitative methods in 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) imaging for risk stratification of hypofunctional thyroid nodules

Abstract

Aim 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) imaging is used for risk stratifications of hypofunctioning thyroid nodules (TNs). MIBI uptake in the nodular tissue is compared to the uptake in the paranodular thyroid tissue. MIBI imaging may be interpreted visually and/or semi-quantitatively. This study aimed to evaluate the interobserver agreement (IOA) of different methods of interpreting MIBI imaging (visual and semi-quantitative approaches).

Methods MIBI imaging data from 2018 to 2020 were collected. Four readers with varying work experience prospectively evaluated MIBI images (planar, SPECT/CT) visually and semi-quantitatively (Wash-Out Index (WOI)). After identifying the nodules on 99mTc-pertechnetate scintigram, the readers evaluated MIBI imaging data by using early, late, early-to-late, and SPECT late acquisitions. Region of interests (ROIs) were defined for semi-quantitative analysis and average counts were calculated using the WOI formula (by Campenni et al.) [1] [2]. IOA was assessed using Fleiss Kappa, Pearson correlation and Analysis of Variance (ANOVA).

Results 23 patients with hypofunctioning nodules were included. Kappa analysis revealed an IOA of 0.57 for all readers for early imaging (moderate agreement); perfect matches were found in 57%. For late imaging, the IOA was 0.48 (moderate) for all, with perfect matches in 48%. The visual pattern (early-to-late) exhibited an IOA of 0.45 for all, with perfect matches in 57%. SPECT/CT evaluation showed an overall IOA of 0.44, with perfect matches in 48%. The semi-quantitative approach WOI yielded an overall result of 0.64 (good agreement) and perfect matches in 91%.

Conclusion The IOA for WOI was higher than for visual methods. The WOI is independent of the reader’s experience level. Visual analysis requires a certain level of experience from the reader.

Keywords

interobserver agreement - MIBI scintigraphy - hypofunctioning thyroid nodules - SPECT imaging - Wash-Out Index

Publication History

Received: 01 March 2024

Accepted after revision: 12 June 2024

Article published online:
17 July 2024

• References

• 1 Reiners C, Schumm-Draeger PM, Geling M. et al. Schilddrüsenultraschallscreening (Initiative Papillon): Bericht über 15 zufällig entdeckte Schilddrüsenkarzinome. Internist 2003; 44: 412-419
• 2 Treglia G, Caldarella C, Saggiorato E. et al. Diagnostic performance of 99mTc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine 2013; 44: 70-78
• 3 Grussendorf M, Ruschenburg I, Brabant G. Malignancy rates in thyroid nodules: a long-term cohort study of 17,592 patients. Eur Thyroid J 2022; 11: e220027
• 4 Schenke S, Klett R, Seifert P. et al. Diagnostic Performance of Different Thyroid Imaging Reporting and Data Systems (Kwak-TIRADS, EU-TIRADS and ACR TI-RADS) for Risk Stratification of Small Thyroid Nodules (≤10 mm). J Clin Med 2020; 9: 236
• 5 Mezosi E, Bajnok L, Gyory F. et al. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules. European Journal of Nuclear Medicine and Molecular Imaging 1999; 26: 798-803
• 6 Schenke SA, Kreissl MC, Grunert M. et al. Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany. Nuklearmedizin 2022; 376-384
• 7 Hurtado-López L, Arellano-Montaño S, Torres-Acosta E. et al. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 2004; 31: 1273-1279
• 8 Eng CY, Quraishi MS, Bradley PJ. Management of Thyroid nodules in adult patients. Head Neck Oncol 2010; 2: 1-11
• 9 Hurtado-López LM, Martínez-Duncker C. Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules. Eur J Nucl Med Mol Imaging 2007; 34: 1701-1703
• 10 Casara D, Rubello D, Saladini G. Role of scintigraphy with tumor-seeking agents in the diagnosis and preoperative staging of malignant thyroid nodules. Biomedicine & Pharmacotherapy 2000; 54: 334-336
• 11 de Koster EJ, de Geus-Oei LF, Dekkers OM. et al. Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules. Endocrine Reviews 2018; 39: 154-191
• 12 Kresnik E, Gallowitsch HJ, Mikosch P. et al. Technetium-99m-MIBI Scintigraphy of Thyroid Nodules in an Endemic Goiter Area. The Journal of Nuclear Medicine 1997; 38: 62-65
• 13 Schenke SA, Klett R, Acker P. et al. Interobserver Agreement of Planar and SPECT Tc99m-MIBI Scintigraphy for the Assessment of Hypofunctioning Thyroid Nodules. Nuklearmedizin 2019; 58: 258-264
• 14 Kim SJ, Lee SW, Jeong SY. et al. Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid 2018; 28: 1339-1348
• 15 Giovanella L, Campenni A, Treglia G. et al. Molecular imaging with 99mTc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur J Nucl Med Mol Imaging 2016; 43: 1018-1026
• 16 Riazi A, Kalantarhormozi M, Nabipour I. et al. Technetium-99m methoxyisobutylisonitrile scintigraphy in the assessment of cold thyroid nodules: is it time to change the approach to the management of cold thyroid nodules?. Nuclear Medicine Communications 2014; 35: 51-57
• 17 Hurtado-Lopez L, Arellano-Montaño S, Torres-Acosta E. et al. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 2004; 31: 1273-1279
• 18 Schenke S, Zimny M, Rink T. et al. 99mTc-MIBI-Szintigraphie hypo funktioneller Schilddrüsenknoten: Vergleich von planarer und tomographischer Technik. Nuklearmedizin 2014; 53: 105-110
• 19 Schmidt M, Schenke S. Update 2019 zur MIBI-Szintigrafie bei hypofunktionellen Schilddrüsenknoten. Nuklearmediziner 2019; 42: 174-182
• 20 Saggiorato E, Angusti T, Rosas R. et al. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med 2009; 50: 1785-1793
• 21 Baumgarten J, Happel C, Ackermann H. et al. Evaluation der Intra- und Inter observerübereinstimmung von99mTc-MIBI-Szintigraphien bei hypofunktionellen Knoten. Nuklearmedizin 2017; 56: 132-138
• 22 Campennì A, Siracusa M, Ruggeri RM. et al. Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep 2017; 7: 1-6
• 23 Campennì A, Giovanella L, Siracusa M. et al. 99m Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology. Thyroid 2016; 26: 1101-1109
• 24 Landis JR, Koch GG. The Measurement of Observer Agreement for Categorical Data. Biometrics 1977; 33: 159-174
• 25 Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J: L. Erlbaum Associates; 1988
• 26 Schenke SA, Campennì A, Tuncel M. et al. Diagnostic Performance of 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study. Diagnostics (Basel) 2022; 12: 1-13
• 27 Ma J, Yang J, Chen C. et al. Use of 99mTc-sestamibi SPECT/CT imaging in predicting the degree of pathological hyperplasia of the parathyroid gland: semi-quantitative analysis. Quant Imaging Med Surg 2021; 11: 4375-4388
• 28 Listewnik MH, Piwowarska-Bilska H, Kurantowicz M. et al. Semi-quantitative method for the assessment of focal lesions in parathyroid scintigraphy with relation to histopathology: a prospective study. Nuclear Medicine Review 2017; 20: 18-24